Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficient targeted DNA methylation with chimeric dCas9–Dnmt3a–Dnmt3L methyltransferase
Peter Stepper, Goran Kungulovski, Renata Z. Jurkowska, et al.
Nucleic Acids Research (2016) Vol. 45, Iss. 4, pp. 1703-1713
Open Access | Times Cited: 277

Showing 1-25 of 277 citing articles:

The diverse roles of DNA methylation in mammalian development and disease
Max Greenberg, Déborah Bourc’his
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 10, pp. 590-607
Closed Access | Times Cited: 1697
The CRISPR tool kit for genome editing and beyond
Mazhar Adli
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 1458
The DNA methyltransferase family: a versatile toolkit for epigenetic regulation
Frank Lyko
Nature Reviews Genetics (2017) Vol. 19, Iss. 2, pp. 81-92
Closed Access | Times Cited: 1176
Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
James K. Nuñez, Jin Chen, Greg C. Pommier, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2503-2519.e17
Open Access | Times Cited: 519
An enhanced CRISPR repressor for targeted mammalian gene regulation
Nan Cher Yeo, Alejandro Chavez, Alissa Lance‐Byrne, et al.
Nature Methods (2018) Vol. 15, Iss. 8, pp. 611-616
Open Access | Times Cited: 455
High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 375
CRISPR technologies for precise epigenome editing
Muneaki Nakamura, Yuchen Gao, Antonia A. Dominguez, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 1, pp. 11-22
Closed Access | Times Cited: 353
CRISPR/Cas9 for cancer research and therapy
Tianzuo Zhan, Niklas Rindtorff, Johannes Betge, et al.
Seminars in Cancer Biology (2018) Vol. 55, pp. 106-119
Open Access | Times Cited: 274
Engineering the next generation of cell-based therapeutics
Caleb J. Bashor, Isaac B. Hilton, Hozefa S. Bandukwala, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 655-675
Open Access | Times Cited: 260
CRISPR/Cas9-Based Engineering of the Epigenome
Julián Pulecio, Nipun Verma, Eva Mejía-Ramírez, et al.
Cell stem cell (2017) Vol. 21, Iss. 4, pp. 431-447
Open Access | Times Cited: 253
Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion
Xiao Wang, Jianan Li, Ying Wang, et al.
Nature Biotechnology (2018) Vol. 36, Iss. 10, pp. 946-949
Closed Access | Times Cited: 223
dCas9-based epigenome editing suggests acquisition of histone methylation is not sufficient for target gene repression
Henriette O’Geen, Chonghua Ren, Charles M. Nicolet, et al.
Nucleic Acids Research (2017) Vol. 45, Iss. 17, pp. 9901-9916
Open Access | Times Cited: 208
High-content CRISPR screening
Christoph Bock, Paul Datlinger, Florence M. Chardon, et al.
Nature Reviews Methods Primers (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 207
Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein
Jiexin Li, Zhuojia Chen, Feng Chen, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 10, pp. 5684-5694
Open Access | Times Cited: 196
Targeted DNA methylation in vivo using an engineered dCas9-MQ1 fusion protein
Yong Lei, Xiaotian Zhang, Jianzhong Su, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 194
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A
Yung‐Hsin Huang, Jianzhong Su, Yong Lei, et al.
Genome biology (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 183
Gene editing and CRISPR in the clinic: current and future perspectives
Matthew P. Hirakawa, Raga Krishnakumar, Jerilyn A. Timlin, et al.
Bioscience Reports (2020) Vol. 40, Iss. 4
Open Access | Times Cited: 168
Epigenome plasticity in plants
James P. B. Lloyd, Ryan Lister
Nature Reviews Genetics (2021) Vol. 23, Iss. 1, pp. 55-68
Closed Access | Times Cited: 123
Advances in CRISPR therapeutics
Michael Chavez, Xinyi Chen, Paul B. Finn, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 1, pp. 9-22
Open Access | Times Cited: 115
CRISPR technologies for genome, epigenome and transcriptome editing
Lukas Villiger, Julia Joung, Luke W. Koblan, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 464-487
Closed Access | Times Cited: 75
Drugging the epigenome in the age of precision medicine
Taylor Feehley, Colm P. O’Donnell, John Mendlein, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 73
DNA methylation in mammalian development and disease
Zachary D. Smith, Sara Hetzel, Alexander Meissner
Nature Reviews Genetics (2024)
Open Access | Times Cited: 35
A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs
Christian Pflueger, Dennis Eng Kiat Tan, Tessa Swain, et al.
Genome Research (2018) Vol. 28, Iss. 8, pp. 1193-1206
Open Access | Times Cited: 149
Mammalian DNA methyltransferases: new discoveries and open questions
Humaira Gowher, Albert Jeltsch
Biochemical Society Transactions (2018) Vol. 46, Iss. 5, pp. 1191-1202
Open Access | Times Cited: 148
Understanding RNA modifications: the promises and technological bottlenecks of the ‘epitranscriptome’
Matthias Schaefer, Utkarsh Kapoor, Michael F. Jantsch
Open Biology (2017) Vol. 7, Iss. 5, pp. 170077-170077
Open Access | Times Cited: 142
Page 1 - Next Page

Scroll to top